Peters Malte
SEC insider (Form 3/4/5 filer). CIK 0001876563. President & CEO at Tango Therapeutics, Inc. (TNGX) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jan 8, 2026. Located in BOSTON, MA.
Companies Peters Malte has filed insider reports for
- Tango Therapeutics, Inc. (TNGX): Director, Officer, President & CEO
- HOOKIPA Pharma Inc. (HOOK): Director, Officer, Chief Executive Officer
Peters Malte
CIK: 0001876563
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (40.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (60.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jan 8, 2026TNGX
Tango Therapeutics, Inc.
AwardDirect350K shares- - Nov 3, 2025TNGX
Tango Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
150K shares- - Aug 19, 2025HOOK
HOOKIPA Pharma Inc.
SaleDirect25.2K shares at avg. $0.82$21K - Jul 22, 2025HOOK
HOOKIPA Pharma Inc.
SaleDirect29.2K shares at avg. $0.92$27K - Jun 5, 2025TNGX
Tango Therapeutics, Inc.
AwardDirect6.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 8, 2026 |  TNGX Tango Therapeutics, Inc. | Award | 350,000 | - | $0 | Direct |
| Nov 3, 2025 | TNGX Tango Therapeutics, Inc. | Award Stock Option (Right to Buy) | 150,000 | - | - | Direct |
| Aug 19, 2025 |  HOOK HOOKIPA Pharma Inc. | Sale | 25,172 | $0.82 | $20,684 | Direct |
| Jul 22, 2025 | HOOK HOOKIPA Pharma Inc. | Sale | 29,176 | $0.92 | $26,842 | Direct |
| Jun 5, 2025 | TNGX Tango Therapeutics, Inc. | Award | 6,250 | - | - | Direct |
1-5 of 5 transactions